Functional analysis of Hsp70 inhibitors

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schlecht, Rainer ^a,d   Scholz, Sebastian R ^a,d   Dahmen, Heike ^c   Wegener, Ansgar ^c   Sirrenberg, Christian ^c   Musil, Djordje ^c   Bomke, Joerg ^c   Eggenweiler, Hans Michael ^c   Mayer, Matthias P ^a   Bukau, Bernd ^a,b  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Merck Serono GmbH   (Germany)

^d ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLETHYNESULFONAMIDE; ANTINEOPLASTIC AGENT; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 INHIBITOR; UNCLASSIFIED DRUG; VER 155008;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG TARGETING; IN VITRO STUDY; NUCLEOTIDE BINDING SITE; PROTEIN CONFORMATION; PROTEIN DOMAIN;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DESIGN; HSC70 HEAT-SHOCK PROTEINS; HUMANS; HYDROLYSIS; LUCIFERASES; MOLECULAR CONFORMATION; PROTEIN ISOFORMS; PROTEIN REFOLDING; PROTEIN STRUCTURE, TERTIARY; PURINE NUCLEOSIDES; SULFONAMIDES;

EID: 84893203556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078443     Document Type: Article

References (58)

1. Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475: 324-332. doi:10.1038/nature10317.
2. Pearl LH, Prodromou C (2006) Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271-294. doi:10.1146/annurev.biochem.75.103004.142738. (Pubitemid 44118034)
3. Anckar J, Sistonen L (2011) Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem 80: 1089-1115. doi:10.1146/annurev-biochem-060809-095203.
4. Guisbert E, Yura T, Rhodius VA, Gross CA (2008) Convergence of molecular, modeling, and systems approaches for an understanding of the Escherichia coli heat shock response. Microbiol Mol Biol Rev 72: 545-554. doi:10.1128/MMBR.00007- 08.
5. Beere HM, Green DR (2001) Stress management - heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol 11: 6-10. (Pubitemid 32056181)
6. Broadley SA, Hartl FU (2009) The role of molecular chaperones in human misfolding diseases. FEBS LETTERS 583: 2647-2653. doi:10.1016/j.febslet. 2009.04.029.
7. Mayer MP, Bukau B (2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 62: 670-684. doi:10.1007/s00018-004-4464- 6.
8. Pierpaoli EV, Gisler SM, Christen P (1998) Sequence-specific rates of interaction of target peptides with the molecular chaperones DnaK and DnaJ. Biochemistry 37: 16741-16748. doi:10.1021/bi981762y. (Pubitemid 28543936)
9. Schmid D, Baici A, Gehring H, Christen P (1994) Kinetics of molecular chaperone action. Science 263: 971-973. (Pubitemid 24094562)
10. Mayer MP, Schröder H, Rüdiger S, Paal K, Laufen T, et al. (2000) Multistep mechanism of substrate binding determines chaperone activity of Hsp70. Nat Struct Biol 7: 586-593. doi:10.1038/76819. (Pubitemid 30445917)
11. Mosser DD, Morimoto RI (2004) Molecular chaperones and the stress of oncogenesis. Oncogene 23: 2907-2918. doi:10.1038/sj.onc.1207529. (Pubitemid 38638852)
12. Clarke PA, Hostein I, Banerji U, Stefano FD, Maloney A, et al. (2000) Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone. Oncogene 19: 4125-4133. doi:10.1038/sj.onc. 1203753.
13. Powers MV, Jones K, Barillari C, Westwood I, van Montfort RLM, et al. (2010) Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 9: 1542-1550.
14. Nylandsted J, Brand K, Jaattela M (2000) Heat shock protein 70 is required for the survival of cancer cells. Annals of the New York Academy of Sciences 926: 122-125. (Pubitemid 32050149)
15. Powers MV, Clarke PA, Workman P (2008) Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14: 250-262. doi:10.1016/j.ccr.2008.08.002.
16. Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49: 377-389. doi:10.1021/ci800324m.
17. Zuiderweg ERP, Bertelsen EB, Rousaki A, Mayer MP, Gestwicki JE, et al. (2012) Allostery in the Hsp70 Chaperone Proteins. Top Curr Chem. doi:10.1007/128-2012-323.
18. Vogel M, Bukau B, Mayer MP (2006) Allosteric regulation of Hsp70 chaperones by a proline switch. Molecular Cell 21: 359-367. doi:10.1016/j. molcel. 2005.12.017.
19. Qi R, Sarbeng EB, Liu Q, Le KQ, Xu X, et al. (2013) Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP. Nat Struct Mol Biol: 1-10. doi:10.1038/nsmb.2583.
20. Zhuravleva A, Clerico EM, Gierasch LM (2012) An interdomain energetic tug-of-war creates the allosterically active state in Hsp70 molecular chaperones. Cell 151: 1296-1307. doi:10.1016/j.cell.2012.11.002.
21. Kityk R, Kopp J, Sinning I, Mayer MP (2012) Structure and Dynamics of the ATP-Bound Open Conformation of Hsp70 Chaperones. Molecular Cell 48: 821-823. doi:10.1016/j.molcel.2012.09.023.
22. Kampinga HH, Craig EA (2010) The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 11: 579-592. doi:10.1038/nrm2941.
23. Chang L, Bertelsen EB, Wisén S, Larsen EM, Zuiderweg ERP, et al. (2008) High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK. Analytical Biochemistry 372: 167-176. doi:10.1016/j.ab.2007.08.020. (Pubitemid 350116767)
24. Williamson DS, Borgognoni J, Clay A, Daniels Z, Dokurno P, et al. (2009) Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design. J Med Chem 52: 1510-1513. doi:10.1021/jm801627a.
25. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, et al. (2006) Smallmolecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nature chemical biology 2: 474-479. doi:10.1038/nchembio809. (Pubitemid 44266309)
26. Leu JI-J, Pimkina J, Frank A, Murphy ME, George DL (2009) A Small Molecule Inhibitor of Inducible Heat Shock Protein 70. Molecular Cell 36: 15-27. doi:10.1016/j.molcel.2009.09.023.
27. Leu JIJ, Pimkina J, Pandey P, Murphy ME, George DL (2011) HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells. Molecular Cancer Research 9: 936-947. doi:10.1158/1541-7786.MCR-11-0019.
28. Schlecht R, Erbse AH, Bukau B, Mayer MP (2011) Mechanics of Hsp70 chaperones enables differential interaction with client proteins. Nat Struct Mol Biol 18: 345-351. doi:10.1038/nsmb.2006.
29. Theyssen H, Schuster HP, Packschies L, Bukau B, Reinstein J (1996) The second step of ATP binding to DnaK induces peptide release. Journal of Molecular Biology 263: 657-670. doi:10.1006/jmbi.1996.0606. (Pubitemid 26395058)
30. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, et al. (2004) SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics 5: 75-86. doi:10.1023/B:JSFG. 0000029237.70316.52. (Pubitemid 39030623)
31. Andréasson C, Fiaux J, Rampelt H, Mayer MP, Bukau B (2008) Hsp110 is a nucleotide-activated exchange factor for Hsp70. J Biol Chem 283: 8877-8884. doi:10.1074/jbc.M710063200.
32. Haslberger T, Zdanowicz A, Brand I, Kirstein J, Turgay K, et al. (2008) Protein disaggregation by the AAA+ chaperone ClpB involves partial threading of looped polypeptide segments. Nat Struct Mol Biol 15: 641-650. doi:10.1038/nsmb.1425. (Pubitemid 351799133)
33. Szabo A, Langer T, Schröder H, Flanagan J, Bukau B, et al. (1994) The ATP hydrolysis-dependent reaction cycle of the Escherichia coli Hsp70 system DnaK, DnaJ, and GrpE. Proc Natl Acad Sci USA 91: 10345-10349. (Pubitemid 24328993)
34. Gässler CS, Wiederkehr T, Brehmer D, Bukau B, Mayer MP (2001) Bag-1M accelerates nucleotide release for human Hsc70 and Hsp70 and can act concentration-dependent as positive and negative cofactor. J Biol Chem 276: 32538-32544. doi:10.1074/jbc.M105328200.
35. Henrich B, Bergamaschi A, Broennimann C, Dinapoli R, Eikenberry EF, et al. (2009) PILATUS: A single photon counting pixel detector for X-ray applications. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 607: 247-249. doi:10.1016/j.nima.2009.03.200.
36. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66: 125-132. doi:10.1107/S0907444909047337.
37. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67: 235-242. doi:10.1107/S0907444910045749.
38. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132. doi:10.1107/S0907444904019158. (Pubitemid 41742764)
39. Scieglinska D, Piglowski W, Chekan M, Mazurek A, Krawczyk Z (2011) Differential expression of HSPA1 and HSPA2 proteins in human tissues; tissue microarray-based immunohistochemical study. Histochem Cell Biol 135: 337-350. doi:10.1007/s00418-011-0791-5.
40. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, et al. (2005) Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 19: 570-582. doi:10.1101/gad.305405. (Pubitemid 40314989)
41. Massey AJ, Williamson DS, Browne H, Murray JB, Dokurno P, et al. (2010) A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol 66: 535-545. doi:10.1007/s00280-009-1194-3.
42. Sondermann H, Scheufler C, Schneider C, Höhfeld J, Hartl FU, et al. (2001) Structure of a Bag/Hsc70Complex: ConvergentFunctional Evolution of Hsp70Nucleotide Exchange Factors. Science 291: 1553-1557. (Pubitemid 32179223)
43. Laufen T, Mayer MP, Beisel C, Klostermeier D, Mogk A, et al. (1999) Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc Natl Acad Sci USA 96: 5452-5457. (Pubitemid 29234638)
44. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, et al. (2000) Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97: 7871-7876. (Pubitemid 30460740)
45. Brehmer D, Rüdiger S, Gässler CS, Klostermeier D, Packschies L, et al. (2001) Tuning of chaperone activity of Hsp70 proteins by modulation of nucleotide exchange. Nat Struct Biol 8: 427-432. doi:10.1038/87588. (Pubitemid 32381290)
46. Balaburski GM, Leu JI-J, Beeharry N, Hayik S, Andrake MD, et al. (2013) A modified HSP70 inhibitor shows broad activity as an anticancer agent. Molecular Cancer Research. doi:10.1158/1541-7786.MCR-12-0547-T.
47. Brodsky JL (1999) Selectivity of the molecular chaperone-specific immunosuppressive agent 15-deoxyspergualin: modulation of Hsc70 ATPase activity without compromising DnaJ chaperone interactions. Biochem Pharmacol 57: 877-880.
48. Fewell SW, Day BW, Brodsky JL (2001) Identification of an inhibitor of hsc70-mediated protein translocation and ATP hydrolysis. J Biol Chem 276: 910-914. doi:10.1074/jbc.M008535200. (Pubitemid 32096508)
49. Nadeau K, Nadler SG, Saulnier M, Tepper MA, Walsh CT (1994) Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry 33: 2561-2567. (Pubitemid 24099664)
50. Nadler SG, Dischino DD, Malacko AR, Cleaveland JS, Fujihara SM, et al. (1998) Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin. Biochemical and Biophysical Research Communications 253: 176-180. doi:10.1006/bbrc.1998.9775. (Pubitemid 29015620)
51. Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, et al. (1994) Phase II study of deoxyspergualin in metastatic breast cancer. Invest New Drugs 12: 235-241. (Pubitemid 24376409)
52. Plowman J, Harrison SD, Trader MW, Griswold DP, Chadwick M, et al. (1987) Preclinical antitumor activity and pharmacological properties of deoxyspergualin. Cancer Research 47: 685-689. (Pubitemid 17027956)
53. Fewell SW, Smith CM, Lyon MA, Dumitrescu TP, Wipf P, et al. (2004) Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity. J Biol Chem 279: 51131-51140. doi:10.1074/jbc.M404857200. (Pubitemid 40017855)
54. Otvos L, O I, Rogers ME, Consolvo PJ, Condie BA, et al. (2000) Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39: 14150-14159.
55. Otvos L, Wade JD, Lin F, Condie BA, Hanrieder J, et al. (2005) Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J Med Chem 48: 5349-5359. doi:10.1021/jm050347i. (Pubitemid 41114906)
56. Zhu X, Zhao X, Burkholder WF, Gragerov A, Ogata CM, et al. (1996) Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272: 1606-1614. (Pubitemid 26200017)
57. Liebscher M, Roujeinikova A (2009) Allosteric coupling between the lid and interdomain linker in DnaK revealed by inhibitor binding studies. Journal of Bacteriology 191: 1456-1462. doi:10.1128/JB.01131-08.
58. O'Brien MC, Flaherty KM, McKay DB (1996) Lysine 71 of the chaperone protein Hsc70 Is essential for ATP hydrolysis. J Biol Chem 271: 15874-15878. (Pubitemid 26236194)